Back to VRDN
Hennion & Walsh Asset Management, Inc. → VRDN
Hennion & Walsh Asset Management, Inc. VRDN Position History
Viridian Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$5.2M
Q3 2026
Peak value
$5.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $3.3M |
| Q4 2025 | $5.3M |
| Q1 2026 | $3.4M |
| Q2 2026 | $3.8M |
| Q3 2026 | $5.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $5.2M | 254.8K | — | — |
| Q2 2026 | $3.8M | 209.1K | — | — |
| Q1 2026 | $3.4M | 174.9K | — | — |
| Q4 2025 | $5.3M | 169.2K | — | — |
| Q3 2025 | $3.3M | 154.3K | — | — |
Other funds holding VRDN
$112.5M
$112.5M
$91.4M
$46.7M
$42.8M